Apatinib enhances chemosensitivity of ABT‐199 in diffuse large B‐cell lymphoma
Sign Up to like & getrecommendations! Published in 2022 at "Molecular Oncology"
DOI: 10.1002/1878-0261.13309
Abstract: To investigate the effect of Apatinib (an inhibitor targeting VEGFR‐2) enhances chemosensitivity of ABT‐199 on diffuse large B‐cell lymphoma (DLBCL). Viability assay and flow cytometric assay for determining apoptosis, cell cycle, mitochondrial membrane potential, reactive… read more here.
Keywords: cell; abt 199; dlbcl; enhances chemosensitivity ... See more keywords